Emcure Pharmaceuticals inaugurates R&D centre in Gujarat

23 Jan 2025 Evaluate

Emcure Pharmaceuticals has inaugurated its state-of-the-art Formulation Research and Development (R&D) Centre near Tapovan Circle, Ahmedabad. The Emcure Research Centre (ERC) is strategically designed to enable breakthroughs in complex drug delivery systems, such as sustained-release formulations, liposomal injections and advanced dermal therapies. 

The new ERC facility is designed to accelerate pharmaceutical innovation with state-of-the-art laboratories and advanced equipment for each of the dosage forms. From early-stage pre-formulation studies to scaling-up, the ERC seamlessly integrates all aspects of pharmaceutical development while adhering to global regulatory standards.

With a focus on sustainable solutions and green chemistry practices, ERC reflects the company’s dedication to environmentally conscious innovations. It also serves as a catalyst for job creation and collaborations with academic institutions, industry experts and regulatory bodies, promoting an ecosystem of shared knowledge and growth.

Emcure Pharmaceuticals is one of the leading Indian pharmaceutical companies engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.


Emcure Pharma Share Price

1017.00 -7.65 (-0.75%)
27-Mar-2025 09:26 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1731.20
Dr. Reddys Lab 1162.35
Cipla 1483.00
Lupin 2019.20
Zydus Lifesciences 891.05
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...